E

EB Pharma Developments (Private limited company)

BE 0780.755.671 Active ●Alkerstraat 28, 3570 Alken

EB Pharma Developments is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0780.755.671. It was founded on 21-01-2022. Its registered office is in Alken. Its main activity is: Other professional, scientific and technical activities. Its annual accounts for 2025 report equity of € 5 298 and a loss of € 1 347. Addrly gives it a financial health grade of B, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 4 financial years.

Information last updated on 18-10-2026.

Company information

Status
Active
Enterprise number
BE 0780.755.671
VAT registered
Yes
Founded
21-01-2022
Latest accounts
2025
Employees
-
Region
Flanders
Establishments
1
Filing record
On time 4 of 4 years
Peppol e-invoicing
Registered
Registered office
Alkerstraat 28, 3570 Alken
Main activity
Other professional, scientific and technical activities
NACE activities
74999 Autres activités des professions libérales et autres activités scientifiques et techniques, nca
72101 Recherche-développement en biotechnologie
72109 Recherche-développement en autres sciences physiques et naturelles

Key figures of EB Pharma Developments

2025202420232022
Profit / loss
iWhat the period earned after taxes. A negative amount is a loss.
€ -1 347€ 3 567€ -4 644€ 16 222
Equity
iWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company.
€ 5 298-68 %€ 16 645+27 %€ 13 078-26 %€ 17 722
Total assets
iEverything the company owns. Equal to total equity and liabilities, which says how it is financed.
€ 16 951-11 %€ 19 064+46 %€ 13 078-41 %€ 22 037
Gross margin
iSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else.
€ -1 127€ 3 749€ -4 297€ 20 964
Employees (FTE)
iAverage number of workers over the period, in full-time equivalents.
----

Financial estimate

Financial health grade B, on a scale from A (safest) to E (most at risk)
Health barometer
The failure probability and the indicators behind this grade are visible with a free account.
Create a free account
Illustrative preview
Detected events
Appointments, capital, registered office, proceedings, extracted from the official acts.
Create a free account
Illustrative preview
Directors & mandates
1 mandate on record in the annual accounts.
Create a free account

Similar companies

Other companies in the same activity in Alken.

CompanyTown
Anima Research 3570 Alken
Havermarkt 26 3570 Alken
ENVIRO ENGINEERING 3570 Alken
NUT 3570 Alken
YO SPILTIJNS 3570 Alken
SODAFISH 3570 Alken
APPLIC-ON 3570 Alken
Elise Buntinx 3570 Alken
Looking for more information about EB Pharma Developments?
The free plan gives you 20 complete company dossiers every month, no card required: health barometer, directors, company links and detected events.
Create a free account

Frequently asked questions

Is EB Pharma Developments still active? Yes. The Crossroads Bank for Enterprises lists EB Pharma Developments as active.

What is the VAT number of EB Pharma Developments? The VAT number of EB Pharma Developments is BE 0780.755.671.

When was EB Pharma Developments founded? EB Pharma Developments was founded on 21-01-2022.

What is the address of EB Pharma Developments? The current registered office of EB Pharma Developments is Alkerstraat 28, 3570 Alken.

When did EB Pharma Developments last file annual accounts? The latest annual accounts of EB Pharma Developments were filed on 25-03-2026.

Does EB Pharma Developments file its annual accounts on time? Yes. EB Pharma Developments filed its annual accounts within the legal deadline for each of its last 4 financial years.

Is EB Pharma Developments financially healthy? Addrly gives EB Pharma Developments a financial health grade of B, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.

Is EB Pharma Developments profitable? The annual accounts of EB Pharma Developments for 2025 show a loss of € 1 347.

What is the equity of EB Pharma Developments? The equity of EB Pharma Developments was € 5 298 at the close of the 2025 financial year.

Who are the directors of EB Pharma Developments? The annual accounts of EB Pharma Developments record 1 mandate. The name, role and dates are visible with a free account.

Can EB Pharma Developments receive Peppol e-invoices? Yes. EB Pharma Developments is registered on the Peppol network and can receive structured electronic invoices.

What does EB Pharma Developments do? The main activity of EB Pharma Developments is: Other professional, scientific and technical activities.

Sources

How Addrly builds and refreshes this data